Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus

Mediators of Inflammation

Volumn 8, Issue 1, 1999, Pages 17-23

  Lapa E Silva, J R ^b   Ruffie C ^a   Lefort, J ^a   Nahori, M A ^a   Vargaftig, B B ^a   Pretolani, M ^a  

^a INSERM   (France)

^b NONE

Author keywords

Eosinophils; Immunohistochemistry; Immunosuppressive drugs; T lymphocytes; 4 integrins

Indexed keywords

ACETYLCHOLINE; IMMUNOSUPPRESSIVE AGENT; OVALBUMIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHILIA; GUINEA PIG; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032914029     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359990676     Document Type: Article

References (36)

1. 1. NHLBI/WHO report. Global initiative for asthma. Global strategy for asthma management and prevention. National Institutes of Health 1995; Publication number 95-3659.
2. 2. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434.
3. 3. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033.
4. 4. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501.
5. 5. Holgate ST. Asthma: past, present and future. Eur Respir J 1993; 6: 1507.
6. 6. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140: 1745.
7. 7. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthmatics. Am Rev Respir Dis 1990 142: 1407.
8. 8. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis 1990; 141: 970.
9. 9. Kay AB, Ying S, Varney B, et al. Messenger RNA expression of the cytokine gene cluster, interleukin-3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775.
10. 10. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298.
11. 11. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541.
12. 12. Pretolani M, Vargaftig BB. From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models? Biochem Pharmacol 1993; 45: 791.
13. 13. Pretolani M, Lefort J, Vargaftig BB. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacological modulation and triggering role of the booster injection. Am Rev Respir Dis 1988; 138: 1572.
14. 14. Lapa e Silva JR, Bachelet CM, Pretolani M, Baker D, Scheper RJ, Vargaftig BB. Immunopathologic alterations in the bronchi of immunized guinea-pigs. Am J Respir Cell Mol Biol 1993; 9: 44.
15. 15. Pretolani M, Ruffié C, Joseph D, et al. Role of eosinophil activation in the bronchial reactivity of allergic guinea-pigs. Am J Respir Crit Care Med 1994; 149: 1167.
16. 16. Wegner C, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990; 247: 456.
17. 17. Lobb RR, Hemler ME. The pathophysiologic role of α4 integrins in vivo. J Clin Invest 1994; 94: 1722.
18. 18. Pretolani M, Ruffié C, Lapa e Silva JR, Joseph D, Lobb RR, Vargaftig BB. Antibody to very-late activation antigen-4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea-pig airways. J Exp Med 1994; 180: 795.
19. 19. Bishop DK, Li W. Cyclosporin and FK506 mediate differential effects on T-cell activation in vivo. J Immunol 1992; 148: 1049.
20. 20. de Paulis R, Cirillo R, Ciccarelli A, de Crescenzo G, Oriente A, Marone G. Characterization of the anti-inflammatory effect of FK506 on human mast cells. J Immunol 1992; 147: 4278.
21. 21. Hatfield SM, Rohem NW. Cyclosporin and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther 1992; 260: 680-688.
22. 22. Gleich GJ, Loegering DA, Macdonald JE. Identification of a major basic protein in guinea-pig eosinophil granules. J Exp Med 1973; 137: 1459.
23. 23. Hunt TC, Summers JA, Campos MG, et al. Monoclonal antibodies specific for guinea-pig major basic protein: their use in an ELISA, immunocytochemistry and flow cytometry. Clin Exp Allergy 1994; 23: 425.
24. 24. Lefort J, Nahori M-A, Ruffié C, Vargaftig BB, Pretolani M. In vivo neutralization of eosinophil-derived major-basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea-pigs. J Clin Invest 1996; 97: 1117.
25. 25. Tan BTG, Ekellar F, Luirink J, Rimmelzaan G, de Jonge AJR, Scheper RJ. Production of monoclonal antibodies defining guinea-pig T-cell surface markers and a strain 13 Ia-like antigen: the value of immunohistological screening. Hybridoma 1985; 4: 115.
26. 26. Schäfer H, Burger R. Identification and functional characterization of guinea-pig CD4: antibody binding transduces a negative signal on T-cell activation. Immunology 1991; 72: 261.
27. 27. Pulido R, Elices MJ, Campanero MR, et al. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J Biol Chem 1991; 266: 10241.
28. 28. Weg VB, Williams TJ, Lobb RR, Nourshargh S. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 1993; 177: 561.
29. 29. Zucker-Franklin D, Grusky G. The identification of eosinophil colonies in soft-agar cultures by differential staining for peroxidase. J Histochem Cytochem 1976; 24: 1270.
30. 30. Thornill MH, Haskard DO. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J Immunol 1990; 145: 865.
31. 31. Pober JS, Lapierre LA, Stolpen AH et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin-1 species. J Immunol 1987; 138: 3319.
32. 32. Lopez AF, Elliott MJ, Woodcock J, Vadas MA. GM-CSF, IL-3 and IL-5: cross-competition on human haemopoietic cells. Immunol. Today 1992; 13: 495.
33. 33. Migita K, Eguchi K, Kawabe Y, Tsukada T, Mizokami A, Nagataki S. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 1995; 96: 727.
34. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146: 374.
35. 35. Nagai H, Yamaguchi S, Tanaka H, Inagaki N. Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. Int Arch Allergy Immunol 1995; 108: 189.
36. 36. Nakata A, Kaminura O, Mori A et al. Evidence that cyclosporin A and dexamethasone inhibit allergic airway eosinophillic inflammation via suppression of interleukin-5 synthesis by T cells. Br J Pharmacol 1998; 124: 1425.